Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules
HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) ("the Company" or "Decoy"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to target shared viral mechanisms conserved across virus families,...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Digistore24 Announces the Return of Club24 Bringing Together Top Affiliates, Founders and Entrepreneurs
- Seager Co. and Benchmade Unveil Limited-Edition Collection Inspired by the American West
- PIRELLI: BOARD OF DIRECTORS MAJORITY APPROVES US MULTI-YEAR INVESTMENT PLAN OF APPROXIMATELY €1 BILLION
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →